Report Company Directory

Athersys

• Monthly LMI Update Independent Investment Research by Independent Investment Research
• Dropping Coverage of Three Biotech Companies by William Blair
• Vaccinations Reach 46%, Adolescent Approval Likely to Reverse Downward Trend in Administrations; Outbreak in India Continues by William Blair
• Today's NeuroNavigator Calls: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET by William Blair
• First-Dose Vaccinations Continue to Decline; Outbreak in India Continues, Showing Initial Signs of Slowing Growth by William Blair
• Fast Forward No. 543 by William Blair
• NeuroNavigator REMINDER: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET by William Blair
• Fast Forward No. 545 by William Blair
• First Dose Vaccinations Begin Declining After Breaking 50% in Adults; Outbreak in India Continues by William Blair
• NeuroNavigator Call Miniseries: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET by William Blair

Athira Pharma

• Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates by GlobeNewsWire
• Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND by GlobeNewsWire
• Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates by GlobeNewsWire
• Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting by GlobeNewsWire
• Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases by GlobeNewsWire
• Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease by GlobeNewsWire
• Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates by GlobeNewsWire
• Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Association International Conference (AAIC) 2024 by GlobeNewsWire
• Athira Pharma Announces Last Patient Completed LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease by GlobeNewsWire
• InsiderInsights.com Daily Ratings Report: June 25, 2024 by InsiderInsights.com

ATHON ENERGIA ESG I FUNDO DEINVESTIMENTO EM PARTICIPACOES EM INFRAESTRUTURA

ATHOS Immobilien AG

• Athos Immobilien AG: 1 director by SmartInsider
• Monthly LMI Update Independent Investment Research by Independent Investment Research
• ValuEngine Toronto Quantitative Stock Report for ATH by ValuEngine Inc
• ValuEngine Toronto Quantitative Stock Report for ATH by ValuEngine Inc
• ValuEngine Toronto Quantitative Stock Report for ATH by ValuEngine Inc
• ValuEngine Toronto Quantitative Stock Report for ATH by ValuEngine Inc
• Feasibility Study Results in December to be a Catalyst for this Junior by Fundamental Research
• Ford Equity International Rating and Forecast Report by Ford Equity Research

ATI Airtest Technologies Inc.

• ATI Airtest Technologies Inc: 1 director by SmartInsider
• AirTest Signs New Arizona Distributor by Newsfile Corp.
• AirTest Director Increases Investment by Newsfile Corp.
• Department of Transportation for Large Midwest State Standardizes on AirTest Products by Newsfile Corp.
• AirTest Oversubscribes $1,000,000 Private Placement by Newsfile Corp.
• AirTest Engages the Howard Group to Direct Capital Market Communications Programs by Newsfile Corp.
• AirTest Is Pleased to Announce the Addition of Ted Konyi as CEO and Director by Newsfile Corp.
• AirTest Announces Management Update by Newsfile Corp.
• Airtest Initiates Trading on Frankfurt Stock Exchange by Newsfile Corp.
• AirTest Products Used in Two Major LA Office Developments by Newsfile Corp.